Cargando…
Ductal Carcinoma In Situ: What the Pathologist Needs to Know and Why
Ductal carcinoma in situ is a proliferation of malignant epithelial cells confined to the ductolobular system of the breast. It is considered a pre-cursor lesion for invasive breast cancer and when identified patients are treated with some combination of surgery, +/− radiation therapy, and +/adjuvan...
Autor principal: | Bane, Anita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580892/ https://www.ncbi.nlm.nih.gov/pubmed/23476791 http://dx.doi.org/10.1155/2013/914053 |
Ejemplares similares
-
PD−L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2021) -
Variability in grading of ductal carcinoma in situ among an international group of pathologists
por: van Seijen, Maartje, et al.
Publicado: (2021) -
Correction: PD − L1 immunostaining: what pathologists need to know
por: Akhtar, Mohammed, et al.
Publicado: (2022) -
Tissue management in precision medicine: What the pathologist needs to know in the molecular era
por: Souza da Silva, Ricella, et al.
Publicado: (2022) -
Grading Ductal Carcinoma In Situ (DCIS) of the Breast – What’s Wrong with It?
por: Cserni, Gábor, et al.
Publicado: (2019)